Natural Biocon (India) Limited is a Fertilizers & Agrochemicals company. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 0 | 1 | 14 | 8 | 3 |
| EBITDA (ex other income) | 0 | 0 | 0 | 0 | (0) |
| margin % | 18.4 | 19.8 | 1.7 | 0.7 | (1.5) |
| Owners' profit | 0 | 0 | 0 | 0 | (0) |
| EPS, as reported (₹) | 0.01 | 0.02 | 0.01 | 0.02 | 0.02 |
| ROE % · ROCE % | 0.5 · 0.7 | 1.5 · 2.0 | 1.2 · 1.8 | 0.1 · 0.2 | (0.1) · (0.1) |
| Debt / equity (x) | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Cash from operations | 0 | 0 | (0) | 0 | 0 |
| Capex | (0) | 0 | 0 | 0 | 0 |
| ₹ crore | Q1 FY25 | Q2 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 5 | 1 | 2 | 0 | 0 | 1 | 0 |
| Profit before tax | 0 | 0 | (0) | 0 | (0) | (0) | (0) | (0) |
| Net profit | 0 | 0 | (0) | 0 | (0) | (0) | (0) | (0) |
| EPS (₹) | 0.01 | 0.02 | 0.19 | 0.05 | 0.02 | 0.02 | 0.04 | 0.00 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| UPL LIMITED | 48,414 | 23.7 | 1.17 | 6.5 | 5.4 | 5.5 | 6.0 | 16.3 |
| PI INDUSTRIES LTD | 34,337 | 29.4 | 3.06 | 16.2 | 11.8 | 14.5 | 8.0 | 25.3 |
| SUMITOMO CHEM INDIA LTD | 23,762 | 41.0 | 7.00 | 29.6 | 16.0 | 20.8 | 4.1 | 28.9 |
| BAYER CROPSCIENCE LTD | 17,895 | 26.0 | 6.03 | — | 23.2 | 27.3 | — | 22.7 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 9 Sept 2026 · Board appoints 4 new directors, accepts resignations of 3 | management changes | medium | — | — |
| 5 Sept 2026 · Board approves 34th AGM on Sep 30, appoints two independent directors | board shareholder meetings | low | — | — |
| 1 Sept 2026 · Board meeting on Sept 5, 2026 to approve AGM notice and related items | board shareholder meetings | low | — | — |
| 11 Aug 2026 · Board Meeting on Aug 14, 2026 for Q1 FY27 Results and Auditor Change | results | low | — | — |
| 14 Jul 2026 · Two directors resign from Natural Biocon board | management changes | high | — | — |
| 11 Jul 2026 · RTA files quarterly compliance certificate under SEBI Regulation 74(5) | compliance | minimal | — | — |
| 18 Jun 2026 · Trading Window Closed by Natural Biocon (India) Ltd | compliance | minimal | — | — |
| 6 Jun 2026 · AGM | board shareholder meetings | low | — | — |
| 5 Jun 2026 · Appointment of Ms. Shruti Sharma (M. No.: A52723) as Company Secretary and Compliance Officer of the Company w.e.f. 05th June, 2026. | management changes | medium | — | — |
| 30 May 2026 · Reg 24A | compliance | minimal | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions |
| SHARDA CROPCHEM LTD. |
| 6,910 |
| 11.0 |
| 2.20 |
| 5.7 |
| 21.7 |
| 25.2 |
| 17.1 |
| 20.5 |
| DHANUKA AGRITECH LTD | 4,359 | 14.9 | 3.11 | 9.7 | 21.2 | 27.0 | 12.7 | 27.4 |
| RALLIS INDIA LTD | 3,833 | 23.9 | 2.26 | 12.9 | 9.7 | 12.5 | — | 0.9 |
| NACL INDUSTRIES LIMITED | 3,709 | 310.4 | 5.43 | 45.4 | 0.7 | 1.4 | 5.9 | 11.3 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 43.8 | 20.1 | 23 of 27 | 15% |
| P/B | 0.3 | 2.4 | 1 of 28 | 100% |
| ROCE | (0.1) | 12.5 | 24 of 29 | 18% |
| ROE | (0.1) | 9.2 | 23 of 28 | 19% |
| Debt / Equity | 0.0 | 0.3 | 5 of 29 | 86% |
| Revenue growth | (100.0) | (0.8) | 28 of 28 | 0% |
| Profit growth | (108.4) | 18.1 | 27 of 28 | 4% |
| Market cap | 9 | 1540 | 28 of 29 | 4% |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
